None listed
Conditions
Brief summary
This project aims to test a comprehensive clinical approach to reducing cardiovascular risk in patients with severe mental illness. Alarming as it is that people with severe mental illness (schizophrenia, schizoaffective disorder, bipolar disorder, depressive psychosis) have 13-30 fewer years of life expectancy than the rest of the population, of even greater concern is that this gap is widening. Most deaths in this group are from chronic physical illnesses especially cardiovascular disease. Guidelines on identifying and managing physical health risk factors are available but poorly implemented. The problem lies at the disjuncture between mental and physical illness. Mental health services do not routinely focus on the physical health of their patients, partly because they do not have clinical systems to integrate physical and mental health and primary care likewise. Similarly, patients have limited access to services and motivational interventions whose focus is to address physical health in the context of complex psychosocial issues. Our research team has used a rigorous process, including extensive piloting, to develop an intervention which delivers recommended physical health care to reduce cardiovascular risk and improve quality of life. Components of this intervention are integrated using the Flinders Program of chronic condition management which places the patient at the centre of their care and provides a recovery-oriented framework. The first project aim is to use a randomised trial to evaluate the effectiveness and cost-effectiveness of the intervention. The main outcome measures will be cardiovascular risk and quality of life. Patients will be recruited from the SA state clozapine register and psychiatric clinics. The second aim is to identify essential components, enablers and barriers at patient, clinical and organizational levels for national sustained implementation of recommended physical health care delivery to people with severe mental illness.
Interventions
A 12-month 2-group randomised controlled trial with extended follow up to 24 months for the intervention group will be conducted to compare the Flinders Program intervention in addition to usual care, with usual care alone. The Flinders Program incorporating cardiovascular risk interventions. It provides a framework and tools to engage the patient in a collaborative structured self management assessment, tailored planning, motivational enhancement, disease management, prevention, coordination and outcome measurement. It drives optimal use of current health services. It structures and provides motivational processes for: A quitting program, control of triglycerides and diabetes; one-on-one and group components of weight reduction programs; and initiation and adherence with BP-lowering and lipid medications. It can be delivered by any clinician and for the trial it will be delivered by trial mental health nurses. The overall duration of the intervention is 20 weeks. The patient first completes the Partners in Health (PIH) scale to self-assess self-management knowledge, shared decision making, symptom management, adherence to medical management, impact of condition/s, and lifestyle behaviours. The nurse then conducts the Cue and Response (C&R) interview to understand patient strengths and barriers to change. This leads to shared decisions on issues requiring action. Nurse and patient identify the patient’s main (life) problem and set a medium term goal using the Problem and Goals tool (P&G). The Flinders Care Plan is used to document action issues for patient and nurse over the following 6-12 months. At scheduled follow-ups, the nurse monitors outcomes using PIH and P&G scores, helps the patient to achieve goals using motivational and problem-solving approaches, and uses the structured framework of the Care Plan to manage activities. The Flinders Program therefore integrates relevant evidence-based patient education programs and agreed medical, psychiatric and community services. The program can be delivered face-to-face, by phone and/or electronically to suit patient needs. A web version of the program allows patient and trial nurse to develop the care plan either face-to-face or via the web and is used for communication in real time, or asynchronously via text or email, to provide monitoring and motivational enhancement. Number, duration and frequency of Flinders Program sessions conducted by the mental health nurse with the participant will be as follows: - (Week1) 1 hour for the completion of the PIH Scale and C&R interview; - (Week2) 1 hour for completion of the P&G and Care Plan - (Week 4, 6, 8, 12, 16 and 20) 30 minutes for each scheduled follow-up sessions. It is critical to engage GPs of SMI patients. For this trial, GPs will be engaged early through their collaboration with the patient and nurse regarding the issues identified in the Care Plan. GPs' role in providing usual physical health care (such as routine blood tests and prescription of lipid-lowering and BP medication will sit alongside the self-management Care Planning process. Integration of the GP role will be enabled via the Care Plan's ability to be finalised by the GP with MBS care plan eligibility (GPMP and TCA items) and trial-nurse follow-up and liaison between GP and patient where needed. The sampling population will be patients of Southern Adelaide Local Health Network (SALHN), population 360,000.
Sponsors
Study design
Eligibility
Inclusion criteria
Diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, or depressive psychosis confirmed using the Mini-international neuropsychiatric interview; taking antipsychotic medication for at least the past 2 months with the intention of continuing for the study duration; age at least 30 years which allows estimation of absolute CVD risk and matches patient age profile; and at least one risk factor (overweight/obesity, smoking, high blood pressure, blood lipids, glucose or diabetes).
Exclusion criteria
Inability to give informed consent; low English literacy; active psychosis or suicidality